• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOX4 在尿路上皮膀胱癌中的表达水平。

SOX4 expression levels in urothelial bladder carcinoma.

机构信息

Department of Medical Biology and Genetics, Ondokuz Mayis University, Faculty of Medicine, 55139, Samsun, Turkey.

出版信息

Pathol Res Pract. 2011 Jul 15;207(7):423-7. doi: 10.1016/j.prp.2011.05.005. Epub 2011 Jun 15.

DOI:10.1016/j.prp.2011.05.005
PMID:21680105
Abstract

High levels of SOX4 gene expression have been reported in a variety of human cancers. The protein may function in the apoptosis pathway, leading to cell death as well as to tumorigenesis. The aim of this study was to investigate the levels of SOX4 expression in bladder cancer. Urinary bladder tumor samples were obtained from 57 bladder cancer and 13 normal bladder biopsies. The levels of SOX4 expression in bladder cancer were determined by immunohistochemistry and real-time PCR. SOX4 gene expression was increased 2.2 times in bladder tumors as compared with normal tissue. The presence of protein was confirmed by immunostaining. There were significant differences between immunostaining of bladder tumors and normal bladder tissue (P=0.001). The present data suggest that SOX4 gene may have a role in bladder cancer tumorigenesis.

摘要

SOX4 基因表达水平在多种人类癌症中均有报道。该蛋白可能在凋亡途径中发挥作用,导致细胞死亡和肿瘤发生。本研究旨在探讨膀胱癌中 SOX4 表达水平。收集 57 例膀胱癌和 13 例正常膀胱活检组织的尿液膀胱肿瘤样本。通过免疫组织化学和实时 PCR 检测膀胱癌中 SOX4 的表达水平。与正常组织相比,膀胱癌中 SOX4 基因表达增加了 2.2 倍。免疫染色证实了蛋白的存在。膀胱癌的免疫染色与正常膀胱组织之间存在显著差异(P=0.001)。本研究数据表明,SOX4 基因可能在膀胱癌发生中起作用。

相似文献

1
SOX4 expression levels in urothelial bladder carcinoma.SOX4 在尿路上皮膀胱癌中的表达水平。
Pathol Res Pract. 2011 Jul 15;207(7):423-7. doi: 10.1016/j.prp.2011.05.005. Epub 2011 Jun 15.
2
Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.膀胱癌中 RE CK 和 EMMPRIN 的表达降低与肿瘤侵袭性有关。
Pathobiology. 2011;78(3):123-31. doi: 10.1159/000323563. Epub 2011 May 26.
3
SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization.SOX4在膀胱癌中的表达:临床特征及体外功能特性
Cancer Res. 2006 Apr 1;66(7):3434-42. doi: 10.1158/0008-5472.CAN-05-3456.
4
Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.瞬时受体电位香草酸亚型2(TRPV2)在人膀胱正常尿路上皮及尿路上皮癌中的表达:与病理分期的相关性
Eur Urol. 2008 Sep;54(3):612-20. doi: 10.1016/j.eururo.2007.10.016. Epub 2007 Oct 16.
5
Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.TSC1/错构瘤蛋白、14-3-3σ和p27表达与pTa/pT1期尿路上皮膀胱癌患者肿瘤预后的相关性
Am J Clin Pathol. 2008 Jun;129(6):918-23. doi: 10.1309/D81QMXPMC3QHT57Y.
6
Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.通过沉默 Dicer、Drosha 和 Exportin 5 诱导膀胱尿路上皮癌的细胞增殖抑制和细胞凋亡。
J Surg Oncol. 2013 Feb;107(2):201-5. doi: 10.1002/jso.23214. Epub 2012 Jul 5.
7
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.膀胱尿路上皮癌中DOC-2/DAB2表达降低。
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4400-6. doi: 10.1158/1078-0432.CCR-07-0287.
8
Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.实时逆转录-聚合酶链反应定量检测膀胱癌中细胞角蛋白20 mRNA的表达
Urology. 2004 Jul;64(1):157-61. doi: 10.1016/j.urology.2004.02.020.
9
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.膀胱癌患者组织学良性尿路上皮中低水平的STK15扩增对膀胱切除术后患者的预后有不良预测作用。
Int J Oncol. 2007 Oct;31(4):793-802.
10
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.胎盘S100(S100P)和GATA3:通过互补DNA微阵列发现的移行上皮和尿路上皮癌标志物。
Am J Surg Pathol. 2007 May;31(5):673-80. doi: 10.1097/01.pas.0000213438.01278.5f.

引用本文的文献

1
as biomarker in hepatitis B virus-associated hepatocellular carcinoma.作为乙型肝炎病毒相关肝细胞癌中的生物标志物。
J Cancer. 2021 Apr 19;12(12):3486-3500. doi: 10.7150/jca.46579. eCollection 2021.
2
Identification of Hub Genes in Hepatocellular Carcinoma Related to Progression and Prognosis by Weighted Gene Co-Expression Network Analysis.基于加权基因共表达网络分析鉴定与肝细胞癌进展和预后相关的枢纽基因。
Med Sci Monit. 2020 Mar 22;26:e920854. doi: 10.12659/MSM.920854.
3
Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.
预测早期膀胱癌疾病进展的干细胞样特征。E2F3和SOX4的作用。
Biomedicines. 2018 Aug 2;6(3):85. doi: 10.3390/biomedicines6030085.
4
MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop.微小 RNA-138 通过 SOX4/p53 反馈环抑制非小细胞肺癌细胞的生长、侵袭和 EMT。
Oncol Res. 2018 Apr 10;26(3):385-400. doi: 10.3727/096504017X14973124850905. Epub 2017 Jun 13.
5
SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis.SOX4 是人类癌症中一个有潜在预后价值的因子:一项系统回顾和荟萃分析。
Clin Transl Oncol. 2016 Jan;18(1):65-72. doi: 10.1007/s12094-015-1337-4. Epub 2015 Aug 7.
6
Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.SOX4表达增加是非小细胞肺癌患者恶性状态和不良预后的生物标志物。
Mol Cell Biochem. 2015 Apr;402(1-2):75-82. doi: 10.1007/s11010-014-2315-9. Epub 2015 Jan 8.
7
Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4.幽门螺杆菌相关性胃癌中miR-204的减少通过靶向SOX4促进癌细胞增殖和侵袭。
PLoS One. 2014 Jul 1;9(7):e101457. doi: 10.1371/journal.pone.0101457. eCollection 2014.
8
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma.SOX4 在原发性胆囊癌中的表达的临床病理意义。
Diagn Pathol. 2012 Apr 17;7:41. doi: 10.1186/1746-1596-7-41.